Search

everythinglearnresearchcommunity

for

Search:↓

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Minoxidil in breast milk may harm nursing infants.

Researchers found a new mutation causing total hair loss from birth.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Effective symptom management in IBD improves quality of life and prevents complications.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Thyroid function may influence hair loss after COVID-19.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Some people with chronic hair loss may have thyroid autoimmunity.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Higher IL-17A levels indicate more severe alopecia areata.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.